Video village, meet iris control: DCS launches lens link for long-range sets ...
Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...
Tom Polen, Becton, Dickinson and Company's Chairman, Chief Executive Officer and President, and Victor Roach, Senior Vice President and Interim Chief Financial Officer. Before we get started, I want ...
Becton Dickinson and Co. (BDX) reported its first-quarter 2026 earnings, surpassing analyst expectations with an adjusted EPS of $2.91 against a forecast of $2.81. Revenue also exceeded projections, ...
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...